Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid A is a highly conserved phosphoglycolipid that serves as the hydrophobic anchor for lipopolysaccharide (LPS) in the outer leaflet of the Gram-negative bacterial outer membrane (Source: NIH). It is vital for maintaining the structural integrity of the bacterial cell envelope and functions as a potent permeability barrier against detergents and antibiotics (Source: PubMed). Clinically, Lipid A is the primary endotoxin responsible for the pathophysiology of Gram-negative sepsis and septic shock (Source: StatPearls). It acts as a pathogen-associated molecular pattern (PAMP) that is recognized by the host's Toll-like receptor 4 (TLR4)/MD-2 complex, initiating a massive pro-inflammatory cytokine cascade (Source: UniProt). Drugs such as polymyxins target Lipid A by binding to its negatively charged phosphate groups, which displaces stabilizing divalent cations and leads to membrane disruption (Source: PubMed). Additionally, novel therapeutic approaches focus on inhibiting Lipid A biosynthesis enzymes, such as LpxC, or neutralizing its activity to prevent overwhelming immune activation (Source: NIH).
Displacement of divalent cations from phosphate groups leading to membrane disruption; inhibition of lipid A biosynthesis; and competitive antagonism of the TLR4/MD-2 receptor complex.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-negative bacterial outer membrane lipid A (Lipid A).